Pharmacovigilance And Drug Safety Software Global Market Report 2024

Description

Pharmacovigilance and drug safety software comprises a suite of digital tools aimed at monitoring, analyzing, and reporting adverse drug reactions (ADRs) and other safety-related information linked to pharmaceuticals and medical products. This software is essential for ensuring patient safety and maintaining regulatory compliance throughout a drug's lifecycle, from development to post-marketing surveillance.

The primary types of pharmacovigilance and drug safety software include adverse event reporting software, drug safety audit software, issue tracking software, and fully integrated software solutions. Adverse event reporting software specifically focuses on tracking, documenting, and managing adverse events associated with pharmaceutical products or medical devices. These solutions are available in both on-premise and cloud-based delivery modes and are utilized by a variety of end users, including pharmaceutical and biotechnology companies, contract research organizations, business process outsourcing firms, and others.

The pharmacovigilance and drug safety software market research report is one of a series of new reports from The Business Research Company that provides pharmacovigilance and drug safety software market statistics, including pharmacovigilance and drug safety software industry global market size, regional shares, competitors with a pharmacovigilance and drug safety software market share, detailed pharmacovigilance and drug safety software market segments, market trends and opportunities, and any further data you may need to thrive in the pharmacovigilance and drug safety software industry. This pharmacovigilance and drug safety software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmacovigilance and drug safety software market size has grown rapidly in recent years. It will grow from $2.00 billion in 2023 to $2.26 billion in 2024 at a compound annual growth rate (CAGR) of 12.9%. The growth observed during the historical period can be attributed to several factors, including a rising demand for pharmacovigilance and drug safety software, an increasing need for advanced pharmacovigilance solutions, escalating healthcare expenditures, a growing prevalence of chronic diseases, and heightened demand for specialized pharmacovigilance software.

The pharmacovigilance and drug safety software market size is expected to see rapid growth in the next few years. It will grow to $3.68 billion in 2028 at a compound annual growth rate (CAGR) of 13.0%. The anticipated growth during the forecast period can be attributed to several factors, including a rise in the incidence of adverse drug reactions (ADRs), the globalization of pharmacovigilance practices, increasing complexity in drug safety regulations, a surge in the development of new drugs and therapies, and a growing number of reported ADRs. Key trends expected to shape this period include the integration of automation and AI, the adoption of cloud-based solutions, ongoing technological innovations, advancements in various technologies, and a continued digitalization of healthcare.

The increasing demand for personalized medicine is projected to drive growth in the pharmacovigilance and drug safety software market in the coming years. Also known as precision medicine, personalized medicine is a healthcare approach that customizes medical decisions and treatments based on the unique characteristics of each patient. This growing demand is influenced by several factors, including enhanced treatment outcomes, a focus on prevention and early detection, and improved cost-effectiveness. Pharmacovigilance and drug safety software play a crucial role in the success of personalized medicine. By integrating pharmacogenetics, real-time data analysis, post-marketing surveillance, and personalized medication information, these tools enhance the safety and efficacy of individualized treatments while supporting robust risk management strategies and addressing ethical considerations. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, a significant increase from six in 2022. Consequently, the rising demand for personalized medicine is driving growth in the pharmacovigilance and drug safety software market.

Leading companies in the pharmacovigilance and drug safety software market are developing innovative technologies, such as cloud-based data lake platforms, to improve patient safety, monitor adverse events more effectively, and enhance regulatory compliance in clinical trials and post-market surveillance of medical devices. A cloud-based data lake platform serves as a scalable, centralized storage system that allows organizations to store, manage, and analyze vast amounts of structured and unstructured data. It provides real-time data access and supports advanced analytics as well as AI/ML workloads. For instance, in December 2023, Thermo Fisher Scientific Inc., a US-based biotechnology firm, launched CorEvidence, a proprietary cloud-based data lake platform designed to enhance pharmacovigilance processes within clinical research registries. This platform aims to optimize case processing and safety data management, particularly for post-authorization safety studies.

In April 2024, Qinecsa, a UK-based company, acquired Insife ApS for an undisclosed amount. This strategic acquisition is intended to strengthen Qinecsa's offerings in end-to-end pharmacovigilance technology solutions, aligning with its ambition to become a leading provider in the digital pharmacovigilance sector. Insife ApS is a Denmark-based company specializing in pharmacovigilance software.

Major companies operating in the pharmacovigilance and drug safety software market are Accenture plc, International Business Machines Corporation, Deloitte Touche Tohmatsu Limited, Oracle Corporation, Capgemini SE, Cognizant Technology Solutions, IQVIA, Wipro Limited, Genepact, Parexel Academy, PharmaLex, Indegene Limited, RXLogix, Sarjen Systems Pvt Ltd, Anju Software Inc., Ennov Group, EXTEDO GmbH, ArisGlobal, AB Cube, Clinevo Technologies

North America was the largest region in the pharmacovigilance and drug safety software market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance and drug safety software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmacovigilance and drug safety software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmacovigilance and drug safety software market includes revenues earned by entities by signal detection and management tools, risk assessment, and management software. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmacovigilance And Drug Safety Software Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmacovigilance and drug safety software market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmacovigilance and drug safety software ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmacovigilance and drug safety software market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Software Type: Adverse Event Reporting Software; Drug Safety Audits Software; Issue Tracking Software; Fully Integrated Software
2) By Delivery Mode: On-premise; Cloud-based
3) By End User: Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Business Process Outsourcing Firms; Other End Users
Companies Mentioned: Accenture plc; International Business Machines Corporation; Deloitte Touche Tohmatsu Limited; Oracle Corporation; Capgemini SE
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r20314

1. Executive Summary

2. Pharmacovigilance And Drug Safety Software Market Characteristics

3. Pharmacovigilance And Drug Safety Software Market Trends And Strategies

4. Pharmacovigilance And Drug Safety Software Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Pharmacovigilance And Drug Safety Software Market Size and Growth

5.1. Global Pharmacovigilance And Drug Safety Software Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Pharmacovigilance And Drug Safety Software Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Pharmacovigilance And Drug Safety Software Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pharmacovigilance And Drug Safety Software Market Segmentation

6.1. Global Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Adverse Event Reporting Software
Drug Safety Audits Software
Issue Tracking Software
Fully Integrated Software
6.2. Global Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
On-premise
Cloud-based
6.3. Global Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Pharmaceutical And Biotechnology Companies
Contract Research Organizations
Business Process Outsourcing Firms
Other End Users

7. Pharmacovigilance And Drug Safety Software Market Regional And Country Analysis

7.1. Global Pharmacovigilance And Drug Safety Software Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Pharmacovigilance And Drug Safety Software Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pharmacovigilance And Drug Safety Software Market

8.1. Asia-Pacific Pharmacovigilance And Drug Safety Software Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pharmacovigilance And Drug Safety Software Market

9.1. China Pharmacovigilance And Drug Safety Software Market Overview
9.2. China Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pharmacovigilance And Drug Safety Software Market

10.1. India Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pharmacovigilance And Drug Safety Software Market

11.1. Japan Pharmacovigilance And Drug Safety Software Market Overview
11.2. Japan Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pharmacovigilance And Drug Safety Software Market

12.1. Australia Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pharmacovigilance And Drug Safety Software Market

13.1. Indonesia Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pharmacovigilance And Drug Safety Software Market

14.1. South Korea Pharmacovigilance And Drug Safety Software Market Overview
14.2. South Korea Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pharmacovigilance And Drug Safety Software Market

15.1. Western Europe Pharmacovigilance And Drug Safety Software Market Overview
15.2. Western Europe Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pharmacovigilance And Drug Safety Software Market

16.1. UK Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pharmacovigilance And Drug Safety Software Market

17.1. Germany Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pharmacovigilance And Drug Safety Software Market

18.1. France Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pharmacovigilance And Drug Safety Software Market

19.1. Italy Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pharmacovigilance And Drug Safety Software Market

20.1. Spain Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pharmacovigilance And Drug Safety Software Market

21.1. Eastern Europe Pharmacovigilance And Drug Safety Software Market Overview
21.2. Eastern Europe Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pharmacovigilance And Drug Safety Software Market

22.1. Russia Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pharmacovigilance And Drug Safety Software Market

23.1. North America Pharmacovigilance And Drug Safety Software Market Overview
23.2. North America Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pharmacovigilance And Drug Safety Software Market

24.1. USA Pharmacovigilance And Drug Safety Software Market Overview
24.2. USA Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pharmacovigilance And Drug Safety Software Market

25.1. Canada Pharmacovigilance And Drug Safety Software Market Overview
25.2. Canada Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pharmacovigilance And Drug Safety Software Market

26.1. South America Pharmacovigilance And Drug Safety Software Market Overview
26.2. South America Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pharmacovigilance And Drug Safety Software Market

27.1. Brazil Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pharmacovigilance And Drug Safety Software Market

28.1. Middle East Pharmacovigilance And Drug Safety Software Market Overview
28.2. Middle East Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pharmacovigilance And Drug Safety Software Market

29.1. Africa Pharmacovigilance And Drug Safety Software Market Overview
29.2. Africa Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pharmacovigilance And Drug Safety Software Market Competitive Landscape And Company Profiles

30.1. Pharmacovigilance And Drug Safety Software Market Competitive Landscape
30.2. Pharmacovigilance And Drug Safety Software Market Company Profiles
- 30.2.1. Accenture plc
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. International Business Machines Corporation
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Deloitte Touche Tohmatsu Limited
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Oracle Corporation
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Capgemini SE
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Pharmacovigilance And Drug Safety Software Market Other Major And Innovative Companies

31.1. Cognizant Technology Solutions
31.2. IQVIA
31.3. Wipro Limited
31.4. Genpact
31.5. Parexel Academy
31.6. PharmaLex
31.7. Indegene Limited
31.8. RXLogix
31.9. Sarjen Systems Pvt Ltd
31.10. Anju Software Inc.
31.11. Ennov Group
31.12. EXTEDO GmbH
31.13. ArisGlobal
31.14. AB Cube
31.15. Clinevo Technologies

32. Global Pharmacovigilance And Drug Safety Software Market Competitive Benchmarking

33. Global Pharmacovigilance And Drug Safety Software Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pharmacovigilance And Drug Safety Software Market

35. Pharmacovigilance And Drug Safety Software Market Future Outlook and Potential Analysis

35.1 Pharmacovigilance And Drug Safety Software Market In 2028 - Countries Offering Most New Opportunities
35.2 Pharmacovigilance And Drug Safety Software Market In 2028 - Segments Offering Most New Opportunities
35.3 Pharmacovigilance And Drug Safety Software Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer